[EN] HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF [FR] INHIBITEURS DE LYSYL OXYDASES DÉRIVÉS D'HALOGÉNOALLYLAMINE PYRAZOLE ET LEURS UTILISATIONS
[EN] INDOLE AND AZAINDOLE HALOALLYLAMINE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF [FR] DÉRIVÉ D'HALOALLYLAMINES INDOLE ET AZAINDOLE COMME INHIBITEURS DE LYSYL OXYDASES, ET LEURS UTILISATIONS
The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I:
wherein A, X, Y R
1
, R
2
, R
3
, R
4
, m and n are as described herein.
The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I:
wherein A, X, Y R
1
, R
2
, R
3
, R
4
, m and n are as described herein.
[EN] PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING<br/>[FR] INHIBITEURS PYRIDILES DE SIGNALISATION HEDGEHOG
申请人:GENENTECH INC
公开号:WO2009126863A2
公开(公告)日:2009-10-15
The invention provides novel inhibitors of hedgehog signaling that are useful as s therapeutic agent for treating malignancies where the compounds have the general formula (I): where A, X, Y R1, R2, R3, R4, m and n are as described herein.
[EN] PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING<br/>[FR] INHIBITEURS PYRIDYLES DE LA SIGNALISATION HEDGEHOG
申请人:GENENTECH INC
公开号:WO2006028958A2
公开(公告)日:2006-03-16
The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y, R1, R2, R3, R4, and n are as described herein.
Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof
申请人:PHARMAXIS LTD.
公开号:US10717734B2
公开(公告)日:2020-07-21
The present invention relates to novel compounds which are capable of inhibiting certain amine oxidase enzymes. These compounds are useful for treatment of a variety of indications, e.g., fibrosis, cancer and/or angiogenesis in human subjects as well as in pets and livestock. In addition, the present invention relates to pharmaceutical compositions containing these compounds, as well as various uses thereof.